Skip to main content
. 2001 Oct 23;2001(4):CD003159. doi: 10.1002/14651858.CD003159

Crook 1996.

Methods multicentre, double blind, randomized, placebo controlled, parallel groups
Participants SDAT mild to moderate; 74 patients received nicergoline, 75 placebo; age > 50 yr.
Interventions Nicergoline or Placebo 30mg. twice a day (os) for 6 months
Outcomes ADAScog, CGIC for efficacy; adverse events for safety
Notes ITT (LOCF) analysis is available